[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:laryngopharyngeal-reflux":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"Laryngopharyngeal reflux",4,3,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04383262","Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction",[12],"Phase 2","RECRUITING","2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.201044Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06999577","The Mechanism Versus PPI Trial",[20],"Phase 4","2026-08-26T02:19:08.862440Z","2026-05-05T02:43:27.592791Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT03418350","The Role of Laryngopharyngeal Reflux in IPF",[],"2026-08-26T02:15:38.131683Z","2026-05-13T02:55:06.123500Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT03853772","The Johns Hopkins Heartburn Center Registry",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:46.655893Z","2026-06-16T05:54:07.969239Z",[],[]]